Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Early Thymic Progenitor Leukemia (ETP-ALL) in Adults: A Distinct Molecular Entity,

Martin Neumann, Sandra Heesch, Claudia Seide, Ouidad Benlasfer, Thomas Burmeister, MD, Stefan Schwartz, MD, Nicola Gökbuget, MD, Dieter Hoelzer, MD, Wolf-Karsten Hofmann, MD, Eckhard Thiel, MD, Claudia D Baldus, MD

Blood (2011) 118 (21): 3551.

https://doi.org/10.1182/blood.V118.21.3551.3551

Published: 2011

Journal Articles

Overexpression of BAALC Indicates Drug Resistance and Inferior Survival in Adult B-Precursor Acute Lymphoblastic Leukemia.

Andrea Kühnl, Nicola Gökbuget, MD, Andrea Stroux, Thomas Burmeister, MD, Martin Neumann, Sandra Heesch, MS, Torsten Haferlach, MD, Dieter Hoelzer, MD, PhD, Wolf Karsten Hofmann, MD, PhD, Eckhard Thiel, MD, Claudia D Baldus, MD

Blood (2009) 114 (22): 1581.

https://doi.org/10.1182/blood.V114.22.1581.1581

Published: 2009

Journal Articles

Early T-Cell Precursor-ALL in Adult T-ALL .

Martin Neumann, Sandra Heesch, Stefan Schwartz, Nicola Gökbuget, Dieter Hoelzer, Torsten Haferlach, Wolf-Karsten Hofmann, Eckhard Thiel, Claudia D Baldus

Blood (2009) 114 (22): 911.

https://doi.org/10.1182/blood.V114.22.911.911

Published: 2009

Journal Articles

Successful Subtype Oriented Treatment Strategies in Adult T-All; Results of 744 Patients Treated in Three Consecutive GMALL Studies.

Blood (2009) 114 (22): 324.

https://doi.org/10.1182/blood.V114.22.324.324

Published: 2009

Journal Articles

Pivotal Phase 2 Study of Weekly Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®) in Adults with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (ALL) in Second Relapse or Progressing Following Two Anti-leukemia Treatment Lines.

Susan O'Brien, MD, Gary Schiller, Lloyd E. Damon, MD, John Lister, MD, Farhad Ravandi, MD, Dan Douer, MD, Aisha Masood, MD, Dina Ben-Yehuda, Jacob M. Rowe, MD, Nicola Gökbuget, Walter Aulitzky, Wendy Stock, MD, Steven Coutre, MD, Leonard Heffner, MD, Melissa L. Larson, MD, Karen Seiter, MD, Anne E Hagey, MD, Steven R. Deitcher, MD, Hagop M. Kantarjian, MD

Blood (2009) 114 (22): 3088.

https://doi.org/10.1182/blood.V114.22.3088.3088

Published: 2009

Journal Articles

Dasatinib (Sprycel®) and Chemotherapy for First-Line Treatment in Elderly Patients with De Novo Philadelphia Positive ALL: Results of the First 22 Patients Included in the EWALL-Ph-01 Trial (on Behalf of the European Working Group on Adult ALL (EWALL))

Blood (2008) 112 (11): 2920.

https://doi.org/10.1182/blood.V112.11.2920.2920

Published: 2008

Journal Articles

High Expression of IL-15 Correlates with Disease Recurrence of Adult B-Lineage Acute Lymphoblastic Leukemia

Shuling Wu, MD, Lars Fischer, Thomas Burmeister, Stefan Schwartz, Michael Notter, Nicola Gökbuget, Dieter Hoelzer, Wolf-Karsten Hofmann, Eckhard Thiel

Blood (2008) 112 (11): 4863.

https://doi.org/10.1182/blood.V112.11.4863.4863

Published: 2008

Journal Articles

High Survival Rate in Adult Burkitt’s Lymphoma/Leukemia and Diffuse Large B-Cell Lymphoma with Mediastinal Involvement.

Dieter Hoelzer, MD, PhD, Wolfgang Hiddemann, MD, PhD, Anita Baumann, MD, Hartmut Döhner, MD, PhD, Ulrich Dührsen, MD, PhD, Rainer Fietkau, MD, PhD, Martin-Leo Hansmann, MD, PhD, Andreas Hüttmann, MD, PhD, Sebastian Irmer, MD, Stephan Kaun, MD, Michael Kneba, MD, PhD, Albrecht Reichle, MD, PhD, Mathias Schmid, MD, PhD, Ingo Schmidt-Wolf, MD, PhD, Eckard Thiel, MD, PhD, Jan Walewski, MD, Nicola Gökbuget, MD

Blood (2007) 110 (11): 518.

https://doi.org/10.1182/blood.V110.11.518.518

Published: 2007

Journal Articles

Improved Outcome in High Risk and Very High Risk ALL by Risk Adapted SCT and in Standard Risk ALL by Intensive Chemotherapy in 713 Adult ALL Patients Treated According to the Prospective GMALL Study 07/2003.

Nicola Gökbuget, MD, Renate Arnold, MD, PhD, Angelika Böhme, MD, PhD, Rainer Fietkau, MD, PhD, Mathias Freund, MD, PhD, Arnold Ganser, MD, PhD, Michael Kneba, MD, PhD, Thomas Lipp, MD, Wolf-Dieter Ludwig, MD, PhD, Georg Maschmeyer, MD, PhD, Dorle Messerer, Harald Rieder, MD, PhD, Eckard Thiel, MD, PhD, Dieter Hoelzer, MD, PhD

Blood (2007) 110 (11): 12.

https://doi.org/10.1182/blood.V110.11.12.12

Published: 2007

Journal Articles

NUP214-ABL1 in adult T-ALL: the GMALL study group experience

Thomas Burmeister, Nicola Gökbuget, Richard Reinhardt, Harald Rieder, Dieter Hoelzer, Stefan Schwartz

Blood (2006) 108 (10): 3556–3559.

https://doi.org/10.1182/blood-2006-04-014514

Published: 2006

Journal Articles

Molecular relapse in adult standard-risk ALL patients detected by prospective MRD monitoring during and after maintenance treatment: data from the GMALL 06/99 and 07/03 trials

Thorsten Raff, Nicola Gökbuget, Silke Lüschen, Regina Reutzel, Matthias Ritgen, Sebastian Irmer, Sebastian Böttcher, Heinz-August Horst, Michael Kneba, Dieter Hoelzer, Monika Brüggemann, for the GMALL Study Group

Blood (2006) 109 (3): 910–915.

https://doi.org/10.1182/blood-2006-07-037093

Published: 2006

Journal Articles

Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia

Monika Brüggemann, Thorsten Raff, Thomas Flohr, Nicola Gökbuget, Makoto Nakao, Jo Droese, Silke Lüschen, Christiane Pott, Matthias Ritgen, Urban Scheuring, Heinz-August Horst, Eckhard Thiel, Dieter Hoelzer, Claus R. Bartram, Michael Kneba, for the German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia

Blood (2006) 107 (3): 1116–1123.

https://doi.org/10.1182/blood-2005-07-2708

Published: 2006

Journal Articles

Measurement of Minimal Residual Disease (MRD) after Consolidation Therapy as a Means of Early Detection of Relapse in Adult Acute Lymphoblastic Leukemia (ALL).

Michael Kneba, MD, PhD, Monika Brüggemann, MD, Nicola Gökbuget, MD, Regina Reutzel, Dieter Hoelzer, MD, PhD, Thorsten Raff, MD

Blood (2005) 106 (11): 538.

https://doi.org/10.1182/blood.V106.11.538.538

Published: 2005

Journal Articles

Early prediction of response in patients with relapsed or refractory Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph + ALL) treated with imatinib

Barbara Wassmann, Heike Pfeifer, Urban J. Scheuring, Anja Binckebanck, Nicola Gökbuget, Johannes Atta, Patrick Brück, Harald Rieder, Claudia Schoch, Lothar Leimer, Rainer Schwerdtfeger, Gerhard Ehninger, Thomas Lipp, Jolanta Perz, Matthias Stelljes, Harald Gschaidmeier, Dieter Hoelzer, Oliver G. Ottmann

Blood (2004) 103 (4): 1495–1498.

https://doi.org/10.1182/blood-2003-01-0154

Published: 2004

Journal Articles

Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia

Dieter Hoelzer, Nicola Gökbuget, Werner Digel, Thomas Faak, Michael Kneba, Regina Reutzel, Joanna Romejko-Jarosinska, Jacek Zwolinski, Jan Walewski

Blood (2002) 99 (12): 4379–4385.

https://doi.org/10.1182/blood-2002-01-0110

Published: 2002

Journal Articles

Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis

Beate Gleißner, Nicola Gökbuget, Claus R. Bartram, Bart Janssen, Harald Rieder, Johannes W. G. Janssen, Christa Fonatsch, Axel Heyll, Dimitris Voliotis, Joachim Beck, Thomas Lipp, Gerd Munzert, Jürgen Maurer, Dieter Hoelzer, Eckhard Thiel, the German Multicenter Trials of Adult Acute Lymphoblastic Leukemia Study Group

Blood (2002) 99 (5): 1536–1543.

https://doi.org/10.1182/blood.V99.5.1536

Published: 2002

Journal Articles

Immunophenotypic and Genotypic Features, Clinical Characteristics, and Treatment Outcome of Adult Pro-B Acute Lymphoblastic Leukemia: Results of the German Multicenter Trials GMALL 03/87 and 04/89

Blood (1998) 92 (6): 1898–1909.

https://doi.org/10.1182/blood.V92.6.1898

Published: 1998

NARROW

Early Thymic Progenitor Leukemia (ETP-ALL) in Adults: A Distinct Molecular Entity,

Overexpression of BAALC Indicates Drug Resistance and Inferior Survival in Adult B-Precursor Acute Lymphoblastic Leukemia.

Early T-Cell Precursor-ALL in Adult T-ALL .

Successful Subtype Oriented Treatment Strategies in Adult T-All; Results of 744 Patients Treated in Three Consecutive GMALL Studies.

Pivotal Phase 2 Study of Weekly Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®) in Adults with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (ALL) in Second Relapse or Progressing Following Two Anti-leukemia Treatment Lines.

Dasatinib (Sprycel®) and Chemotherapy for First-Line Treatment in Elderly Patients with De Novo Philadelphia Positive ALL: Results of the First 22 Patients Included in the EWALL-Ph-01 Trial (on Behalf of the European Working Group on Adult ALL (EWALL))

High Expression of IL-15 Correlates with Disease Recurrence of Adult B-Lineage Acute Lymphoblastic Leukemia

High Survival Rate in Adult Burkitt’s Lymphoma/Leukemia and Diffuse Large B-Cell Lymphoma with Mediastinal Involvement.

Improved Outcome in High Risk and Very High Risk ALL by Risk Adapted SCT and in Standard Risk ALL by Intensive Chemotherapy in 713 Adult ALL Patients Treated According to the Prospective GMALL Study 07/2003.

NUP214-ABL1 in adult T-ALL: the GMALL study group experience

Molecular relapse in adult standard-risk ALL patients detected by prospective MRD monitoring during and after maintenance treatment: data from the GMALL 06/99 and 07/03 trials

Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia

Measurement of Minimal Residual Disease (MRD) after Consolidation Therapy as a Means of Early Detection of Relapse in Adult Acute Lymphoblastic Leukemia (ALL).

Early prediction of response in patients with relapsed or refractory Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph + ALL) treated with imatinib

Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia

Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis

Immunophenotypic and Genotypic Features, Clinical Characteristics, and Treatment Outcome of Adult Pro-B Acute Lymphoblastic Leukemia: Results of the German Multicenter Trials GMALL 03/87 and 04/89

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only